MedPath

Analysis of changes in bacterial flora in the upper gastrointestinal tract due to administration of Rifxima

Not Applicable
Recruiting
Conditions
Patients with cirrhosis with hepatic encephalopathy
Registration Number
JPRN-UMIN000044550
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

When the research subject offers to decline participation in the research or withdraws consent When the entire research is canceled When discontinuing due to unfavorable events such as side effects When the person in charge of research determines that it is appropriate to discontinue the research for other reasons.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the bacterial flora of gastrointestinal tract after administration of rifaximin
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath